Page last updated: 2024-08-24

nsc 338720 and Vomiting

nsc 338720 has been researched along with Vomiting in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bowman, A; Cummings, J; Dunlop, N; French, R; Jodrell, DI; MacLellan, A; Smyth, JF; Stewart, M	1

Trials

1 trial(s) available for nsc 338720 and Vomiting

Article	Year
Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously. British journal of cancer, 1998, Volume: 77, Issue:5 Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cerebellar Ataxia; Dizziness; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Picolines; Treatment Failure; Vomiting	1998

Article

Year

Dose-limiting neurotoxicity in a phase I study of penclomedine (NSC 388720, CRC 88-04), a synthetic alpha-picoline derivative, administered intravenously.

British journal of cancer, 1998, Volume: 77, Issue:5

Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cerebellar Ataxia; Dizziness; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Picolines; Treatment Failure; Vomiting

1998